Neuromuscular junctions - SMA mouse - Thierry Bordet - NSblog- 2

Olesoxime, a first hope for Spinal Muscular Atrophy (SMA) patients

About the author  Thierry Bordet has more than 15 years of experience leading drug discovery efforts from preclinical research to proof-of-concept across biotech and academic settings. At Trophos, Thierry led various drug discovery programs for motor neuron disorders which culminated in the identification of Olesoxime, the first treatment for Spinal Muscular Atrophies (SMA). He has […]